Related Experiment Video
Updated: Apr 28, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
High-altitude pulmonary edema: review
Shuchi Bhagi1, Swati Srivastava, Shashi Bala Singh
1Defence Institute of Physiology and Allied Sciences (DIPAS), Defence Research and Development Organization (DRDO).
High-altitude pulmonary edema (HAPE) is a dangerous condition caused by low oxygen at high altitudes. This review covers HAPE
Area of Science:
- High-altitude medicine
- Environmental physiology
Background:
- High altitude (HA) environments present challenges due to hypobaric hypoxia.
- High-altitude pulmonary edema (HAPE) is a life-threatening condition affecting individuals ascending rapidly to altitudes above 3,000 meters.
- HAPE is influenced by both environmental exposures and individual genetic predispositions.
Purpose of the Study:
- To review the pathological aspects of hypobaric hypoxia, with a specific focus on High-altitude pulmonary edema (HAPE).
- To provide an overview of HAPE for evaluating physiological, biochemical, and genetic responses during acclimatization to high altitudes.
Main Methods:
- Systematic identification and categorization of HAPE facets.
- Literature review encompassing incidence, symptoms, physiological effects, and pathophysiology.
- Inclusion of environmental and genetic risk factors, prevention, and treatment strategies.
Main Results:
- HAPE is a significant cause of mortality at extreme altitudes.
- Understanding HAPE requires examining physiological and genetic factors.
- This review synthesizes current knowledge on HAPE and related high-altitude maladies.
Conclusions:
- Further research into the multifactorial pathogenesis of HAPE is warranted.
- Effective prevention and treatment strategies are crucial for individuals traveling to high altitudes.
- This review serves as a valuable resource for researchers in high-altitude medicine.
More Related Videos
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
07:59Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Related Concept Videos
Pulmonary Edema II: Pathophysiology
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care